Compounds > dipropylacetamide
Page last updated: 2024-08-25

dipropylacetamide and lysine

dipropylacetamide has been researched along with lysine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Canonico, PL; Condorelli, F; Genazzani, AA; Gnemmi, I; Vallario, A1

Other Studies

3 other study(ies) available for dipropylacetamide and lysine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Acetylation; Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Butyrates; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lysine; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Signal Transduction; Transfection; Tumor Suppressor Protein p53; Up-Regulation; Valproic Acid

2008